Antifungal drug resistance in molds: Clinical and microbiological factors
- 25 March 2008
- journal article
- Published by Springer Nature in Current Fungal Infection Reports
- Vol. 2 (1) , 36-42
- https://doi.org/10.1007/s12281-008-0006-2
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Aspergillus flavus: human pathogen, allergen and mycotoxin producerMicrobiology, 2007
- Changing Epidemiology of Rare Mould InfectionsDrugs, 2007
- Changing patterns and trends in systemic fungal infectionsJournal of Antimicrobial Chemotherapy, 2005
- Aspergillus lentulus sp. nov., a New Sibling Species of A. fumigatusEukaryotic Cell, 2005
- Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyondCandida albicansandAspergillus fumigatusJournal of Clinical Microbiology, 2004
- In Vitro Analyses, Animal Models, and 60 Clinical Cases of Invasive Aspergillus terreus InfectionAntimicrobial Agents and Chemotherapy, 2004
- Isolation of Neosartorya pseudofischeri from Blood: First Hint of Pulmonary AspergillosisJournal of Clinical Microbiology, 2004
- Cerebral Aspergillosis Caused byNeosartorya hiratsukae, BrazilEmerging Infectious Diseases, 2002
- Aspergillosis Case-Fatality Rate: Systematic Review of the LiteratureClinical Infectious Diseases, 2001
- An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: Diagnosis and therapeutic outcomeJournal of Infection, 1998